Please login to the form below
New accounts: March
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period December 2004 to February 2005 inclusive.
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period December 2004 to February 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, e-mail nhobson@pmlive.com.
|
|
|
|
|
|
3M Health Care |
Skin portfolio |
Wound care |
The Medical Multimedia Company |
|
Abbott Laboratories |
Kaletra |
HIV |
The Medical Multimedia Company |
|
Baxter Healthcare |
N/A |
Haemodialysis |
The Medical Multimedia Company |
|
BMS |
NHS marketing |
PCO communications |
Medicom Group |
|
BMS |
NHS marketing |
Contract publishing |
Medicom Group |
|
Boehringer Ingelheim/Lilly |
Cymbalta |
Depression |
Discovery London |
|
Boehringer Ingelheim |
Mirapexin |
Parkinson's disease |
Lowe Fusion |
|
Crookes Healthcare |
Pre-launch |
Pre-launch |
Discovery London |
|
GE Healthcare |
New product |
Nuclear medicine |
Lowe Fusion |
|
GE Healthcare |
Steripet |
Nuclear medicine |
Lowe Fusion |
|
GSK/Roche |
Bonviva |
Osteoporosis |
Virgo Health PR |
|
Janssen-Cilag |
Tramacet |
Pain |
Lowe Fusion |
|
Napp Pharmaceuticals |
N/A |
Pain |
Axon Communications |
|
Novartis |
Audit |
Primary care |
Leap Frog Communications |
|
Novartis |
Educational programme |
Transplantation |
Leap Frog Communications |
|
PM Society |
PRIME Training Programme |
N/A |
Helen Lawn & Associates |
|
Replay Media |
Corporate |
N/A |
Helen Lawn & Associates |
|
Sankyo Pharmaceuticals |
Olmetec |
Cardiovascular |
Kendle Healthcare |
|
sanofi-aventis |
Pre-launch |
Pre-launch |
Discovery London |
|
sanofi-aventis |
Eloxatin |
Oncology |
Discovery London |
|
sanofi-aventis |
Sculptra and NewFill |
Dermatology |
Spink Consumer Relations |
|
sanofi-aventis |
Epilim |
Epilepsy |
Discovery London |
|
sanofi-aventis |
Depakote |
Bipolar disorder |
Discovery London |
|
Schering Plough |
Asmanex |
Respiratory disease |
Leap Frog Communications |
|
Shire |
Reminyl XL |
Dementia/CNS |
GCI Healthcare |
|
Straken |
Tostrex |
Hypogonadism |
Medicom Group |
Share
Related Hub content
Subscribe to our email news alerts
- Sanofi and Teva to collaborate on inflammatory bowel disease drug in deal worth $1.5bn
- Eli Lilly to acquire cancer specialist Point Biopharma in deal worth $1.4bn
- Regeneron and Intellia to develop additional gene editing therapies under expanded collaboration
- Novavax’s updated COVID-19 vaccine approved by FDA for emergency use
- Alzheimer’s Research UK awards Cardiff University researchers £387,000
- Actinic keratosis – a common skin condition that can lead to skin cancer
No results were found
PMHub
Mednet Group
PMEA Agency of the year 2021. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC and...
Latest intelligence
- Actinic keratosis – a common skin condition that can lead to skin cancer
- PMGroup talks to Volker Koscielny, Chief Medical Officer at Almirall, about the importance of remaining vigilant about skin checks, the prevalence of actinic keratosis in the UK and the steps...
- Man vs microbe: the fight against antimicrobial resistance
- How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
- Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
- Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...
